|
|
||||||||
on
retinal vessels
1 Departments of Pediatrics,
Using a video-imaging technique, we
characterized the effects of 8-isoprostaglandin
F2
(8-iso-PGF2
) on retinal
vasculature from piglets.
8-Iso-PGF2
potently contracted
(EC50 = 5.9 ± 0.5 nM) retinal
vessels. These effects were completely antagonized by the
cyclooxygenase inhibitor indomethacin, the thromboxane synthase blocker
CGS-12970, the thromboxane receptor antagonist L-670596, and the
putative inhibitor of the non-voltage-dependent receptor-operated
Ca2+ pathway SKF-96365;
constrictor effects of
8-iso-PGF2
were also partly
attenuated by the ETA-receptor
blocker BQ-123 and an inhibitor of endothelin-converting enzyme,
phosphoramidon, but was negligibly affected by the L-type voltage-gated
Ca2+ channel blocker nifedipine.
Correspondingly, 8-iso-PGF2
elicited endothelin release from retinal preparations, which was markedly reduced by SKF-96365.
8-Iso-PGF2
also increased thromboxane production in the retina and cultured endothelial cells,
but not on retinovascular smooth muscle cells; these effects of
8-iso-PGF2
were blocked by
indomethacin, CGS-12970, SKF-96365, and EGTA, but not by nifedipine.
8-Iso-PGF2
also increased Ca2+ transients in retinal
endothelial cells, which were inhibited by SKF-96365 and EGTA, but not
by nifedipine, whereas in smooth muscle cells U-46619, but not
8-iso-PGF2
, stimulated a rise in Ca2+ transients. Finally,
H2O2 + FeCl2 (in vitro) and anoxia
followed by reoxygenation (in vivo) stimulated formation of
8-iso-PGF2
in the retina. In
conclusion, 8-iso-PGF2
-induced
retinal vasoconstriction is mediated by cyclooxygenase-generated
formation of thromboxane and, to a lesser extent, by endothelin after
Ca2+ entry into cells, possibly
through receptor-operated channels. Retinal vasoconstriction to
8-isoprostanes might play a role in the genesis of ischemic
retinopathies.
peroxidation; calcium influx; cyclooxygenase; thromboxane; endothelin
This article has been cited by other articles:
![]() |
S. Brault, F. Gobeil Jr., A. Fortier, J.-C. Honore, J.-S. Joyal, P. S. Sapieha, A. Kooli, E. Martin, P. Hardy, A. Ribeiro-da-Silva, et al. Lysophosphatidic acid induces endothelial cell death by modulating the redox environment Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2007; 292(3): R1174 - R1183. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Cambonie, B. Comte, C. Yzydorczyk, T. Ntimbane, N. Germain, N. L. O. Le, P. Pladys, C. Gauthier, I. Lahaie, D. Abran, et al. Antenatal antioxidant prevents adult hypertension, vascular dysfunction, and microvascular rarefaction associated with in utero exposure to a low-protein diet Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2007; 292(3): R1236 - R1245. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. J. Welch Effects of isoprostane on tubuloglomerular feedback: roles of TP receptors, NOS, and salt intake Am J Physiol Renal Physiol, April 1, 2005; 288(4): F757 - F762. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Catalli and L. J. Janssen Augmentation of bovine airway smooth muscle responsiveness to carbachol, KCl, and histamine by the isoprostane 8-iso-PGE2 Am J Physiol Lung Cell Mol Physiol, November 1, 2004; 287(5): L1035 - L1041. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Belik, R. P. Jankov, J. Pan, M. Yi, C. R. Pace-Asciak, and A. K. Tanswell Effect of 8-isoprostaglandin F2{alpha} on the newborn rat pulmonary arterial muscle and endothelium J Appl Physiol, November 1, 2003; 95(5): 1979 - 1985. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Catalli, D. Zhang, and L. J. Janssen Receptors and signaling pathway underlying relaxations to isoprostanes in canine and porcine airway smooth muscle Am J Physiol Lung Cell Mol Physiol, November 1, 2002; 283(5): L1151 - L1159. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Balazy, T. Iesaki, J. L. Park, H. Jiang, P. M. Kaminski, and M. S. Wolin Vicinal Nitrohydroxyeicosatrienoic Acids: Vasodilator Lipids Formed by Reaction of Nitrogen Dioxide with Arachidonic Acid J. Pharmacol. Exp. Ther., November 1, 2001; 299(2): 611 - 619. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. H. Wright, D. Abran, M. Bhattacharya, X. Hou, S. G. Bernier, A. Bouayad, J.-C. Fouron, A. Vazquez-Tello, M. H. Beauchamp, R. I. Clyman, et al. Prostanoid receptors: ontogeny and implications in vascular physiology Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2001; 281(5): R1343 - R1360. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Hou, L. J. Roberts II, D. F. Taber, J. D. Morrow, K. Kanai, F. Gobeil Jr., M. H. Beauchamp, S. G. Bernier, G. Lepage, D. R. Varma, et al. 2,3-Dinor-5,6-dihydro-15-F2t-isoprostane: a bioactive prostanoid metabolite Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2001; 281(2): R391 - R400. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. H. Beauchamp, A. K. Martinez-Bermudez, F. Gobeil Jr., A. M. Marrache, X. Hou, G. Speranza, D. Abran, C. Quiniou, P. Lachapelle, J. Roberts II, et al. Role of thromboxane in retinal microvascular degeneration in oxygen-induced retinopathy J Appl Physiol, June 1, 2001; 90(6): 2279 - 2288. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. J. Janssen Isoprostanes: an overview and putative roles in pulmonary pathophysiology Am J Physiol Lung Cell Mol Physiol, June 1, 2001; 280(6): L1067 - L1082. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Najarian, A. M. Marrache, I. Dumont, P. Hardy, M. H. Beauchamp, X. Hou, K. Peri, F. Gobeil Jr, D. R. Varma, and S. Chemtob Prolonged Hypercapnia-Evoked Cerebral Hyperemia via K+ Channel- and Prostaglandin E2-Dependent Endothelial Nitric Oxide Synthase Induction Circ. Res., December 8, 2000; 87(12): 1149 - 1156. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. G. Schnackenberg and C. S. Wilcox Two-Week Administration of Tempol Attenuates Both Hypertension and Renal Excretion of 8-Iso Prostaglandin F2{alpha} Hypertension, January 1, 1999; 33(1): 424 - 428. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |